Cargando…
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410835/ https://www.ncbi.nlm.nih.gov/pubmed/34471116 http://dx.doi.org/10.1038/s41467-021-25282-3 |
_version_ | 1783747182847852544 |
---|---|
author | Weigelin, Bettina den Boer, Annemieke Th. Wagena, Esther Broen, Kelly Dolstra, Harry de Boer, Rob J. Figdor, Carl G. Textor, Johannes Friedl, Peter |
author_facet | Weigelin, Bettina den Boer, Annemieke Th. Wagena, Esther Broen, Kelly Dolstra, Harry de Boer, Rob J. Figdor, Carl G. Textor, Johannes Friedl, Peter |
author_sort | Weigelin, Bettina |
collection | PubMed |
description | Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent integration of sublethal damage events, delivered by multiple CTL transiting between individual tumor cells, mediates effective elimination. Reversible sublethal damage includes perforin-dependent membrane pore formation, nuclear envelope rupture and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals below 50 min discriminate between tumor cell death or survival after recovery. In live melanoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable process, whereby accelerating damage magnitude and frequency may improve immune efficacy. |
format | Online Article Text |
id | pubmed-8410835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84108352021-09-22 Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity Weigelin, Bettina den Boer, Annemieke Th. Wagena, Esther Broen, Kelly Dolstra, Harry de Boer, Rob J. Figdor, Carl G. Textor, Johannes Friedl, Peter Nat Commun Article Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent integration of sublethal damage events, delivered by multiple CTL transiting between individual tumor cells, mediates effective elimination. Reversible sublethal damage includes perforin-dependent membrane pore formation, nuclear envelope rupture and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals below 50 min discriminate between tumor cell death or survival after recovery. In live melanoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable process, whereby accelerating damage magnitude and frequency may improve immune efficacy. Nature Publishing Group UK 2021-09-01 /pmc/articles/PMC8410835/ /pubmed/34471116 http://dx.doi.org/10.1038/s41467-021-25282-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Weigelin, Bettina den Boer, Annemieke Th. Wagena, Esther Broen, Kelly Dolstra, Harry de Boer, Rob J. Figdor, Carl G. Textor, Johannes Friedl, Peter Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title_full | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title_fullStr | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title_full_unstemmed | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title_short | Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
title_sort | cytotoxic t cells are able to efficiently eliminate cancer cells by additive cytotoxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410835/ https://www.ncbi.nlm.nih.gov/pubmed/34471116 http://dx.doi.org/10.1038/s41467-021-25282-3 |
work_keys_str_mv | AT weigelinbettina cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT denboerannemieketh cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT wagenaesther cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT broenkelly cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT dolstraharry cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT deboerrobj cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT figdorcarlg cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT textorjohannes cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity AT friedlpeter cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity |